Patents Assigned to Seinda Pharmaceutical Guangzhou Corporation
  • Composition and methods for the treatment of myopia
    Patent number: 11285141
    Abstract: Compositions and methods useful in slowing, inhibiting, or regressing the progression of myopia, while minimizing pupil dilation and light sensitivity are provided herein. Provided compositions can include a muscarinic receptor antagonist and a miotic agent.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: March 29, 2022
    Assignee: Seinda Pharmaceutical Guangzhou Corporation
    Inventors: Hui Ouyang, Yong Qiu